Año: 2023
Journal Impact Factor (JIF): 5.30
Categoría | Edición | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|---|
ONCOLOGY | SCIE | 62/322 | Q1 | T1 | D2 |
Año: 2023
Journal Citation Indicator (JCI): 1,050
Categoría | Posición | Cuartil | Tercil | Decil | Percentil |
---|---|---|---|---|---|
ONCOLOGY | 74/322 | Q1 | T1 | D3 | 77,17 |
Año:
2023
CiteScore:
9,100
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Oncology | 68/404 | Q1 | T1 | D2 |
Cancer Research | 63/230 | Q2 | T1 | D3 |
SJR año:
2023
Factor de Impacto:
2,249
Categoría | Posición | Cuartil | Tercil | Decil |
---|---|---|---|---|
Cancer Research | 40/233 | Q1 | T1 | D2 |
Oncology | 47/397 | Q1 | T1 | D2 |
Agencia | Código de Proyecto |
---|---|
AbbVie | - |
AstraZeneca | - |
Celgene | - |
Daiichi Sankyo | - |
Gilead Sciences | - |
Greenwich LifeSciences | - |
Menarini Group | - |
MolecularHealth | - |
Novartis | - |
Pfizer | - |
Roche | - |
# | Autor | Afiliación |
---|---|---|
1 | University of Cologne (Germany) | |
2 | Hauke, J | University of Cologne (Germany) |
3 | Gelmon, K | British Columbia Cancer Agency (Canada) |
4 | Marmé, F | Ruprecht Karls University Heidelberg (Germany) |
5 | Ernst, C | University of Cologne (Germany) |
6 | Martin, M | CIBERONC (Spain) |
7 | Untch, M | Helios Kliniken (Germany) |
8 | Bonnefoi, H | Institut Bergonie; Institut National de la Sante et de la Recherche Medicale (Inserm) (France) |
9 | Knudsen, E | Roswell Park Comprehensive Cancer Center (USA) |
10 | Im, SA | Seoul National University Hospital (South Korea) |
11 | DeMichele, A | Pennsylvania Medicine (USA) |
12 | Van't Veer, L | University of California San Francisco (USA) |
13 | Kim, SB | University of Ulsan College of Medicine (South Korea) |
14 | Bear, H | VCU Health System (USA) |
15 | McCarthy, N | Breast Cancer Trials Australia (Australia) |
16 | Rhiem, K | University of Cologne (Germany) |
17 | Turner, N | Royal Marsden NHS Foundation Trust (England) |
18 | Witkiewicz, A | Roswell Park Comprehensive Cancer Center (USA) |
19 | Rojo, F | Hosp Univ Fdn Jimenez Diaz (Spain) |
20 | Filipits, M | Medical University of Vienna (Austria) |
21 | Martin, LA | Royal Marsden NHS Foundation Trust (England) |
22 | Fasching, PA | University of Erlangen Nuremberg (Germany) |
23 | Schem, C | Mammazentrum Hamburg (Germany) |
24 | Becker, K | Medical Faculty of the University of Cologne (Germany) |
25 | García-Sáenz, JA | Hospital Clinico San Carlos (Spain) |
26 | Kelly, CM | Trinity College Dublin (Ireland) |
27 | Reimer, T | University of Rostock (Germany) |
28 | Toi, M | Kyoto University (Japan) |
29 | Rugo, HS | UCSF Helen Diller Family Comprehensive Cancer Center (USA) |
30 | Denkert, C | Philipps University Marburg (Germany) |
31 | Gnant, M | Medical University of Vienna (Austria) |
32 | Makris, A | Mount Vernon Cancer Centre (England) |
33 | Liu, Y | Pfizer Italy (Italy) |
34 | Valota, O | Pfizer Italy (Italy) |
35 | Felder, B | German Breast Group (Germany) |
36 | Weber, K | German Breast Group (Germany) |
37 | Nekljudova, V | German Breast Group (Germany) |
38 | Loibl, S | German Breast Group (Germany) |